FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Amgen Gains Expanded Approval for Blincyto

FDA grants Amgen accelerated approval for Blincyto (blinatumomab) and its expanded use to treat adults and children with B-cell precursor acute lympho...

Human Drugs

Insmed NDA for Alis in Lung Disease

Insmed files an NDA for Alis (amikacin liposome inhalation suspension), indicated for treating adult patients with nontuberculous mycobacterial lung d...

Human Drugs

OIG Calls for FDA Supply Chain Education

The HHS Inspector General says FDA should educate drug dispensers about their responsibilities under the Drug Supply Chain Security Act.

Medical Devices

Stakeholders Appreciate IVD Draft Guidance

Three industry stakeholders praise an FDA draft guidance on IVDs and suggest changes.

Medical Devices

FDA Approves Hologic PMA for Clarity HD Breast Imaging

FDA approves a Hologic PMA for its Clarity HD high-resolution 3D imaging and Intelligent 2D imaging technology and their use on the companys 3Dimensio...

Biologics

Bristol-Myers Squibb sBLA for Colorectal Cancer

FDA accepts for review a Bristol-Myers Squibb supplemental BLA for Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for treating certain adu...

Federal Register

Gastrointestinal Drugs Advisory Committee Charter Extended

Federal Register notice: FDA renews for an additional two years the charter for its Gastrointestinal Drugs Advisory Committee.

Human Drugs

Report on Alopecia Patient Perspectives for Drug Development

FDA releases a report entitled The Voice of the Patient: Alopecia Areata that summarizes a 9/2017 public meeting that heard from patients and caregive...

Federal Register

FDA Joint Panel to Review InfaCare Pharma NDA

Federal Register notice: FDA announces a 5/3 joint Gastrointestinal Drugs Advisory Committee and Pediatric Advisory Committee meeting.

Human Drugs

Plaintiffs Need to Prove Newly Acquired Evidence: Attorney

Attorney Steven Boranian says courts are requiring plaintiffs to provide specific facts detailing what drug companies knew about a new risk and when t...